No Data
Jinhai Medical Calls 2026 AGM, Seeks Share Issue Mandate and Director Re-election
JINHAI MED TECH: Annual Report 2025
Jinhai Medical Technology's 2025 Loss Narrows; Shares Drop 12%
Performance: Jin Hai Medical Technology (02225.HK) narrowed its full-year loss to 17.08 million Singapore dollars.
Jinhai Medical Technology (02225.HK) announced its fiscal year 2025 performance, recording revenue of S$46.28 million, representing a year-on-year decrease of 7.9%. The net loss narrowed from S$17.97 million in the previous year to S$17.08 million, with a loss per share of 0.33 cents. No final dividend was declared.
JINHAI MED TECH: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2025
Jinhai Medical Technology (02225.HK) plans to hold a board meeting on March 27 to approve the annual results.
Gelonghui, March 13th丨Jinhai Medical Technology (02225.HK) announced that it will hold a board meeting on March 27, 2026, with the aim of considering and approving (among other things) the annual results announcement for the company and its subsidiaries for the year ended December 31, 2025, as well as the distribution of a final dividend, if applicable.